ABSTRACT
Adipose tissue stromal cells (ADSCs) are prone to functional decline and senescence during metabolic disturbances. In diabetes mellitus (DM), the pathogenic microenvironment induces oxidative stress causing ADSCs to senesce. The senescence associated secretory phenotype (SASP) in turn drives disease progression. The pathogenesis of DM is thus both a cause and consequence of senescence. Therapeutically preventing the onset of senescence in ADSCs may play a significant role in preventing disease progression and directly impact the onset of comorbidities. The purpose of this study was to establish an in vitro model that mimic the DM micro-environment to use as a screening tool to assess the therapeutic efficacy of preventative and restorative agents. Exposing ADSCs (Subject(s)
Adipose Tissue
, Cellular Senescence
, Cellular Senescence/drug effects
, Adipose Tissue/cytology
, Adipose Tissue/metabolism
, Stromal Cells/metabolism
, Humans
, Animals
, Metformin/pharmacology
, Diabetes Mellitus/metabolism
, Diabetes Mellitus/pathology
, Cells, Cultured
, Senescence-Associated Secretory Phenotype
, Reactive Oxygen Species/metabolism
, Tumor Necrosis Factor-alpha/metabolism
, Glucose/metabolism